Summary Safety Review - ZOFRAN (ondansetron) - Assessing the Potential Harm to the Fetus

Name: Summary Safety Review - ZOFRAN (ondansetron) - Assessing the Potential Harm to the Fetus
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

Health Canada carried out a safety review to assess the risk of birth defects with the use of ondansetron, as part of routine health product monitoring and because this drug is not authorized for sale in Canada to treat nausea and vomiting during pregnancy. The use of ondansetron during pregnancy is not recommended because its safety has not been established in pregnant women.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2024-05-10

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Summary Safety Review - ZOFRAN (ondansetron) - Assessing the Potential Harm to the Fetus (English, HTML) HTML
Summary Safety Review - ZOFRAN (ondansetron) - Assessing the Potential Harm to the Fetus (French, HTML) HTML

Related open data

Health Canada